Skip to content

Form 4 filed by Kunkel Lori Anne

Kunkel Lori Anne filed this Form 4 on ELVN (Enliven Therapeutics, Inc.) with 4 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-03 22:21:24 UTC.

Accession
0001536368-26-000008
Filed
2026-11-03
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: ELVN · Enliven Therapeutics, Inc. (CIK 1672619)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Common Stock 2026-10-30M exercised+3,741$1.1245,625D
Common Stock 2026-10-30M exercised+7,300$18.352,925D
Stock Option (right to buy) derivative2026-10-30M exercised-3,741$00D
Stock Option (right to buy) derivative2026-10-30M exercised-7,300$030,582D